Nabiximols Cannabinoid Oromucosal Spray With Temozolomide in Patients With Recurrent Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 1b Randomised, Placebo-Controlled Trial of Nabiximols Cannabinoid Oromucosal Spray With Temozolomide in Patients With Recurrent Glioblastoma
Br. J. Cancer 2021 Feb 24;[EPub Ahead of Print], C Twelves, M Sabel, D Checketts, S Miller, B Tayo, M Jove, L Brazil, SC ShortFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.